Literature DB >> 1553905

High-dose cimetidine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group study.

L Inhorn1, S D Williams, S Nattam, D Stephens.   

Abstract

The Hoosier Oncology Group evaluated cimetidine in 42 patients with metastatic renal cell carcinoma. There were two complete remissions that lasted for 26 and 33+ months in 38 evaluable patients. There were no partial remissions. Toxicity was minimal. Patients with renal cell carcinoma can occasionally respond to cimetidine with long-term remission.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1553905     DOI： 10.1097/00000421-199204000-00012

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


  3 in total

1.  Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis.

Authors:  Toshiaki Kinouchi; Junichi Sakamoto; Taiji Tsukamoto; Hideyuki Akaza; Yoshinobu Kubota; Seiichiro Ozono; Hiroshi Kanetake; Tetsuo Taguchi; Toshihiko Kotake
Journal:  J Cancer Res Clin Oncol       Date:  2006-04-04       Impact factor: 4.553

2.  ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3.

Authors:  Roberto Coppo; Francesca Orso; Federico Virga; Alberto Dalmasso; Desirée Baruffaldi; Lei Nie; Fabiana Clapero; Daniela Dettori; Lorena Quirico; Elena Grassi; Paola Defilippi; Paolo Provero; Donatella Valdembri; Guido Serini; Mehran M Sadeghi; Massimiliano Mazzone; Daniela Taverna
Journal:  Cancer Lett       Date:  2021-04-13       Impact factor: 9.756

3.  Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.